ORPEA |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.87 EUR | -0.29% |
|
-4.77% | -35.70% |
| Mar. 26 | CAC40: ends in green, approaches 8200 points | CF |
| Mar. 26 | CAC40: +0.3%, tops out at 8,180, same gap for US indices | CF |
| Sales 2023 | 5.2B 5.53B | Sales 2024 * | 5.43B 5.78B | Capitalization | 1.73B 1.84B |
|---|---|---|---|---|---|
| Net income 2023 * | -439M -467M | Net income 2024 * | -207M -220M | EV / Sales 2023 | 0.42 x |
| Net Debt 2023 * | 7.54B 8.02B | Net Debt 2024 * | 6.65B 7.07B | EV / Sales 2024 * | 1.54 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-0.01
x | Employees | 76,000 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 95.16% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -0.29% | ||
| 1 week | -4.77% | ||
| Current month | +7.18% | ||
| 1 month | +3.49% | ||
| 3 months | -24.01% | ||
| 6 months | -99.08% | ||
| Current year | -35.70% |
1 week
10.46
11.70
1 month
9.9714.40
Current year
9.9718.10
1 year
9.973 600.00
3 years
9.97111 100.00
5 years
9.97129 000.00
10 years
9.97129 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Laurent Guillot
CEO | Chief Executive Officer | 54 | 22-06-30 |
Laurent Lemaire
DFI | Director of Finance/CFO | - | 21-12-07 |
| Chief Tech/Sci/R&D Officer | - | 22-10-09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 22-07-27 | |
Laurent Guillot
CEO | Chief Executive Officer | 54 | 22-06-30 |
Mireille Faugère
BRD | Director/Board Member | 66 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.13% | 18 M€ | +3.25% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-16 | 10.87 | -0.29% | 81 929 |
| 24-04-15 | 10.9 | -0.27% | 242,671 |
| 24-04-12 | 10.93 | -0.38% | 181,289 |
| 24-04-11 | 10.97 | -1.97% | 158,720 |
| 24-04-10 | 11.19 | -1.93% | 322,430 |
Real-time Euronext Paris, April 16, 2024 at 09:27 am EDT
More quotes
ORPEA is the European leader in global dependency care. The group operates retirement homes, follow-up care clinics, and psychiatric clinics.
At the end of 2022, ORPEA had a network of 992 facilities (90,860 beds) located in France (358 facilities; 33,462 beds), Benelux/the United Kingdom/Ireland (193 facilities; 10,708 beds), Central Europe (237 facilities; 23,765 beds), Eastern Europe (124 facilities; 12,764 beds), the Iberian Peninsula and Latin America (79 facilities; 10,007 beds) and China (1 facility; 154 beds)
The group has a real estate portfolio of nearly 2.3 million m2 with a value of EUR 6,500 million.
Net sales are distributed geographically as follows: France/Benelux/the United Kingdom/Ireland (59.9%), Central Europe (25.6%), Eastern Europe (9.3%), Iberian Peninsula and Latin America (5.1%) and other (0.1%).
Calendar
2024-09-23
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
10.9
EUR
Average target price
7,980
EUR
Spread / Average Target
+73,124.44%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -35.70% | 1.84B | |
| -21.30% | 1.56B | |
| -4.81% | 1.35B | |
| +8.59% | 1.2B | |
| +13.75% | 693M | |
| +2.73% | 489M | |
| +0.50% | 362M | |
| +198.96% | 360M | |
| -6.93% | 117M | |
| +36.31% | 89.02M |
- Stock Market
- Equities
- ORP Stock
